Drug therapy: Bronchodilator therapy (first of two parts).
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D001980:Bronchi / Q000503:physiopathology; D001986:Bronchial Spasm / Q000188:drug therapy / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000502:physiology; D006152:Cyclic GMP / Q000502:physiology; D004809:Ephedrine / Q000494:pharmacology / Q000627:therapeutic use; D004837:Epinephrine / Q000494:pharmacology / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology / Q000627:therapeutic use; D008407:Mast Cells / Q000378:metabolism; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012130:Respiratory Hypersensitivity / Q000378:metabolism; D013189:SRS-A / Q000378:metabolism; D013566:Sympathomimetics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D013189:SRS-A; D013566:Sympathomimetics; D000242:Cyclic AMP; D004809:Ephedrine; D006152:Cyclic GMP; D007545:Isoproterenol; D004837:Epinephrine